Aminoglycoside antibiotics in clinical use.
Aminoglycosides are among the most used antibiotics despite competitive pressure from newer beta-lactam agents. The activity profile, pharmacology, toxicity potential, and methods of toxicity prevention of aminoglycosides are well appreciated after three decades. Nephrotoxicity, ototoxicity, and the added costs of drug level monitoring limit wider usage, but great activity against highly antibiotic resistant gram negative bacteria often outweigh these disadvantages and will likely keep aminoglycosides available for the foreseeable future.
Pancoast
S J
SJ
Temple University School of Medicine, Philadelphia, Pennsylvania.
D058186:Acute Kidney Injury / Q000139:chemically induced; D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy*; D055598:Chemical Phenomena; D002621:Chemistry; D003365:Costs and Cost Analysis; D003638:Deafness / Q000139:chemically induced; D006090:Gram-Negative Bacteria; D006801:Humans
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents